at the 38th Annual EAU Congress
Top-3 Best Patient Poster Award 2023 – 1 st place prize
Top-3 Best Patient Poster Award 2023 – 2 nd place prize
A. Filicevas, Brussels, Belgium
R. Giles, Duivendrecht, The Netherlands - Handed out by M. Jewett
Patient Day Friday, 10 March
Top-3 Best Patient Poster Award 2023 – 3 rd place prize A. Lawler, London, United Kingdom
Best paper published in 2023 by YAU
Best abstract published in 2023 by YAU
G. Gandaglia, Milan, Italy
T. Piramide, Turin, Italy - Handed out by J. Gómez Rivas
YAU Meeting Friday, 10 March
Best reviewer published in 2023 by YAU
R. Bertolo, Rome, Italy
ESTU René Küss Prize 2023 V. Gomez Dos Santos, Madrid, Spain - From left to right: E. Lledo Garcia, V. Gomez Dos Santos, M. Musquera Felip
ESUO Helmut Haas Award 2023
H. Heers, Marburg, Germany - Handed out by H. Haas
Section Awards Saturday, 11 March
Prize for the Best Paper published on Fundamental Research in the Urological Literature L. Au , E. Hatipoglu, M. Robert De Massy, K. Litchfield, G. Beattie, A. Rowan, D. Schnidrig, R. Thompson, F. Byrne, S. Horswell, N. Fotiadis, S. Hazell, D. Nicol, S. Shepherd, A. Fendler, R. Mason, L. Del Rosario, K. Edmonds, K. Lingard, S. Sarker, M. Mangwende, E. Carlyle, J. Attig, K. Joshi, I. Uddin, P. Becker, M. Werner Sunderland, A. Akarca, I. Puccio, W. Yang, T. Lund, K. Dhillon, M. Vasquez, E. Ghorani, H. Xu, C. Spencer, J. López, A. Green, U. Mahadeva, E. Borg, M. Mitchison, D. Moore, I. Proctor, M. Falzon, L. Pickering, A. Furness, J. Reading, R. Salgado, T. Marafioti, M. Jamal-Hanjani, on behalf of the PEACE Consortium, G. Kassiotis, B. Chain,J. Larkin, C. Swanton, S. Quezada, S. Turajlic (London, Sutton, United Kingdom; Bizkaia, Spain; Melbourne, Australia; Antwerp, Belgium) For the paper: “Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma” Cancer Cell 39 (2021); https://doi.org/10.1016/j.ccell.2021.10.001 - Handed out by C. Chapple
Prize for the Best Paper published on Clinical Research in the Urological Literature
G. Basile, M. Bandini, E. Gibb, J. Ross, D. Raggi, L. Marandino, T. Costa De Padua, E. Crupi, R. Colombo, M. Colecchia, R. Lucianò, L. Nocera, M. Moschini, A. Briganti, F. Montorsi, A. Necchi (Milan, Italy; Vancouver, Canada; Massachusetts, New York, United States of America) For the paper: “Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial” Clin Cancer Res (2022); https://doi.org/10.1158/1078-0432.CCR-22-2158040 - Handed out by C. Chapple
Award Gallery Saturday, 11 March
First Prize for the Best Abstract (Oncology)
A. Contreras-Sanz, M. Reike, G. Negri, Z. Htoo, S. Spencer Miko, K. Nielsen, M. Roberts, J. Scurll, K. Ikeda, G. Wang, R. Seiler, G. Morin, P. Black (Vancouver, Canada) For the abstract: “Proteomic profiling of muscle invasive bladder
Second Prize for the Best Abstract (Oncology)
C. Micoli, A. Crippa, A. Discacciati, H. Vigneswaran, T. Palsdottir, M. Clements, M. Aly, J. Adolfsson, W. Fredrik, P. Wiklund, T. James, J. Lindberg, H. Grönberg, L. Egevad, T. Nordström, M. Eklund (Solna, Sweden) For the abstract: “The Stockholm3 prostate cancer screening trial (STHLM3): An interim analysis of mortality results after 6.5 years of follow-up” - Handed out by A. Stenzl
cancer treated with neoadjuvant chemotherapy” - Accepted by M. Reike, handed out by A. Stenzl
First Prize for the Best Abstract (Non-Oncology)
M. Kasten, O. Gross, M. Wettstein, C. Anderson, V. Birkhäuser, J. Borer, M. Koschorke, S. Mccallin, U. Mehnert, H. Sadri, L. Stächele, T. Kessler, L. Leitner (Zürich, Switzerland) For the abstract: “Similar artefact susceptibility for water- and air- filled urodynamic systems: Results from a randomized controlled non-inferiority trial” Supported by the IBSA - From left to right: A. Stenzl, M. Kasten, G. Villa (IBSA)
Best Scientific Paper Award 2023 published in European Urology
S. Siva, M. Bressel, S. Wood, M. Shaw, S. Loi, S. Sandhu, B. Tran, A. Azad, J. Lewin, K. Cuff, H. Liu, D. Moon, J. Goad, L-M. Wong, M. LimJoon, J. Mooi, S. Chander, D. Murphy, N. Lawrentschuk, D. Pryor (Melbourne, Brisbane, Australia) For the paper: “Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma— The RAPPORT Trial” European Urology; Volume 81, Issue 4, P364-372, April 1, 2022 Supported by ELSEVIER - From left to right: J. Catto, D. Murphy on behalf of S. Siva, B. Chen (ELSEVIER)
38th Annual EAU Congress
European Urology Today
April/May 2023
5
Powered by FlippingBook